Bajpai Anurag, Bagga Arvind, Hari Pankaj, Bardia Aditya, Mantan Mukta
Division of Pediatric Nephrology, Department of Pediatrics, All India Institute of Medical Sciences, New Delhi 110 029, India.
Indian Pediatr. 2005 Apr;42(4):321-8.
To evaluate complications in adequately treated children with distal renal tubular acidosis (RTA) and to identify factors influencing their development.
Records of patients with primary distal RTA followed for 2 or more years at this hospital were reviewed. Case records were examined for age at onset of symptoms and at initiation of treatment, treatment details, follow-up and complications. Height, weight and growth velocity were expressed as standard deviation score (SDS) during different periods of follow-up. Regression analysis was performed to evaluate factors influencing increase in height and weight SDS. P value of less than 0.05 was considered significant.
Of 18 patients (eleven boys), the diagnosis was established at the median (range) age of 6 yr (1.5-13 yr). These patients were followed up for a median (range) period of 4 yr (2-18.5 yr). Short stature (height SDS <-2) was noted in all patients at the time of diagnosis with median (range) height SDS of -5.2(-7.5 - -0.4). All patients had failure to thrive with median (range) weight SDS of -3(-5.7 - -1.5). Height SDS increased by median (range) of 2 (1.2-5.5) to become -2.7(-4.8 - -1.1) at last follow-up. Weight SDS increased by median (range) of 0.9 (-0.6 - 2.8) to become -2.4 (-4 - -0.5). Median (range) growth velocity SDS decreased from 3 (1-16) during first year of treatment to 1(-0.3 - 7) at four years with an increase in mean height SDS by 1.3 during the first two years of treatment. Height SDS at last follow-up was not influenced by the age at initiation of treatment, follow-up duration, initial height SDS or severity of acidosis at diagnosis. Increase in height SDS correlated negatively with base excess and height SDS at diagnosis, and positively with follow-up duration on univariate analyses. Initial height SDS was the only factor that influenced increase in height SDS on multivariate analyses. Increase in weight SDS was negatively correlated with base excess and initial weight SDS with significant association with initial weight SDS, on multivariate analyses. All patients had rickets at the time of diagnosis with pathological fractures in four. Rickets resolved without treatment with vitamin D in seventeen patients after a median (range) period of 4 mo (1-12 mo). Eight patients (44.4%) had nephrocalcinosis at diagnosis. Twenty-four hour urine calcium excretion was higher in those with nephrocalcinosis (p = 0.01). Creatinine clearance remained normal in all except one who progressed to renal failure.
There is a need for early diagnosis, appropriate treatment and regular follow-up of patients with distal RTA for improving outcome.
评估接受充分治疗的远端肾小管酸中毒(RTA)患儿的并发症,并确定影响其发生发展的因素。
回顾性分析本院随访2年及以上的原发性远端RTA患者的记录。检查病例记录中的症状出现年龄、治疗开始年龄、治疗细节、随访情况及并发症。在不同随访阶段,身高、体重及生长速度以标准差评分(SDS)表示。进行回归分析以评估影响身高和体重SDS增加的因素。P值小于0.05被认为具有统计学意义。
18例患者(11例男孩),诊断确立时的中位(范围)年龄为6岁(1.5 - 13岁)。这些患者的中位(范围)随访时间为4年(2 - 18.5年)。诊断时所有患者均身材矮小(身高SDS < -2),中位(范围)身高SDS为 -5.2(-7.5 - -0.4)。所有患者均生长发育迟缓,中位(范围)体重SDS为 -3(-5.7 - -1.5)。末次随访时身高SDS中位数(范围)增加2(1.2 - 5.5),变为 -2.7(-4.8 - -1.1)。体重SDS中位数(范围)增加0.9(-0.6 - 2.8),变为 -2.4(-4 - -0.5)。治疗第一年的中位(范围)生长速度SDS从3(1 - 16)降至4年时的1(-0.3 - 7),治疗的前两年平均身高SDS增加1.3。末次随访时的身高SDS不受治疗开始年龄、随访时间、初始身高SDS或诊断时酸中毒严重程度的影响。单因素分析显示,身高SDS的增加与碱剩余和诊断时的身高SDS呈负相关,与随访时间呈正相关。多因素分析显示,初始身高SDS是影响身高SDS增加的唯一因素。多因素分析显示,体重SDS的增加与碱剩余和初始体重SDS呈负相关,与初始体重SDS有显著关联。所有患者诊断时均有佝偻病,4例发生病理性骨折。17例患者在中位(范围)4个月(1 - 12个月)后未经维生素D治疗佝偻病即缓解。8例患者(44.4%)诊断时有肾钙质沉着症。肾钙质沉着症患者的24小时尿钙排泄量更高(p = 0.01)。除1例进展为肾衰竭外,所有患者的肌酐清除率均保持正常。
需要对远端RTA患者进行早期诊断、适当治疗和定期随访以改善预后。